GLP or GCP for bioanalysis? [GxP / QC / QA]

posted by ElMaestro  – Denmark, 2019-01-20 14:54 (1979 d 04:39 ago) – Posting: # 19789
Views: 7,379

Dear nobody,

here I think you are going astray.

it is true the OECD GLP guidance was developed for nonclin./tox studies and this is stated in the preamble section of the document, but there is nothing, not one single paragraph anywhere in Eudralex or any other collection of legal or regulatory documents, which precludes regulators from applying the same standard (or another) in any field.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,059 posts in 4,841 threads, 1,664 registered users;
35 visitors (0 registered, 35 guests [including 7 identified bots]).
Forum time: 20:34 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5